• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Synvista Therapeutics Inc

+ Add to Watchlist

SYNI:US

Price not available for SYNI:US

Snapshot for Synvista Therapeutics Inc (SYNI)

Open: - Day's Range: - Volume: 0
Previous Close: 0.0001 52wk Range: 0.0001 - 0.0800 1-Yr Rtn: -

Stock Chart for SYNI

No chart data available.
  • SYNI:US 0.0001
  • 1M
  • 1Y
0.0001
Interactive SYNI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SYNI

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -6.7900
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 0.00
Shares Outstanding (M) 2.59
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SYNI

No data available

Company Profile & Key Executives for SYNI

Synvista Therapeutics Inc. discovers and develops pharmaceutical products for the treatment of the complications of diabetes and age-related diseases. The Company's proprietary technology focuses on advanced glycosylation end-products formed as a result of circulating blood glucose reacting with proteins.

Noah BerkowitzPresident/CEO/SecretaryJacob VictorExec Dir:Product Devt
More Company Profile & Key Executives for SYNI

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil